Expression level is a key determinant of E2F1-mediated cell fate

Area of Science:

• Molecular Biology
• Cancer Biology
• Cell Cycle Regulation

Background:

• The Rb/E2F network is crucial for cell cycle control and is often dysregulated in cancer.
• E2F1, a key target, paradoxically shows limited overexpression in cancers despite its role in proliferation and apoptosis.

Purpose of the Study:

• To investigate the impact of E2F1 expression levels on cell fate decisions using single-cell analysis.
• To elucidate the quantitative relationship between E2F1 levels and downstream cellular phenotypes.

Main Methods:

• Single-cell quantitative analysis of E2F1 expression.
• RNA-sequencing and RT-PCR to analyze gene expression.
• Treatment of cancer cells with a proteasome inhibitor (MLN2238).

Main Results:

• E2F1 levels determine cell fate: low promotes proliferation, moderate induces cell cycle arrest (G1, G2, M), and high induces apoptosis.
• Gene expression analysis revealed distinct targets activated at different E2F1 levels.
• MLN2238 treatment induced E2F1-dependent mitotic arrest and apoptosis in lung cancer cells.

Conclusions:

• E2F1 expression levels are critical determinants of cell proliferation, cell cycle arrest, and apoptosis.
• Upregulating E2F1 may be a viable therapeutic strategy for various cancer types due to its potent anti-proliferative effects.